1. GPCR/G Protein
  2. CaSR
  3. Calhex 231

Calhex 231是一种强效的负向异构调节剂,能够阻断(IC50 = 0.39 μM)通过激活人类野生型 CaSR 瞬时钙感应受体引发的 [3H] 肌醇磷酸的增加。Calhex 231可用于创伤性出血性休克 (THS) 和糖尿病性心肌病 (DCM) 的研究.

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

Calhex 231 Chemical Structure

Calhex 231 Chemical Structure

CAS No. : 652973-93-8

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

Calhex 231 的其他形式现货产品:

Customer Review

Other Forms of Calhex 231:

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

Calhex 231 is a potent negative allosteric modulator that blocks (IC50 = 0.39 μM) increases in [3H]inositol phosphates elicited by activating the human wild-type CaSR transiently Ca2+-sensing receptor. Calhex 231 can be used in the study of traumatic hemorrhagic shock (THS) and diabetic cardiomyopathy (DCM)[1].

IC50 & Target

CaSR[1]
IC50: 0.39 μM (Inositol phosphate)[1]

体外研究
(In Vitro)

Calhex 231剂量依赖性地抑制了10 mM Ca2+ 诱导的IP反应,其在T764A (IC50 = 0.28 ± 0.05 μM) 和H766A (IC50 = 0.64 ± 0.03 μM) 突变受体中的效力与WT受体中的相似[1].
Calhex 231治疗显著下调CaSR、α-SMA、Col-I/III、MMP2/9的表达。Calhex 231减轻了高糖诱导的心脏成纤维细胞中的心肌纤维化[2].
Calhex 231能够抑制Itch(与阿特罗芬-1相互作用的蛋白4)-泛素蛋白酶体和TGF-β1/Smads途径,然后抑制心脏成纤维细胞的增殖,减少胶原沉积,缓解高糖诱导的心肌纤维化[2].

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Proliferation Assay[2]

Cell Line: Primary neonatal rat cardiac fibroblasts (CFs).
Concentration: 3 µM.
Incubation Time: 24 hours.
Result: Significantly decreased the proliferation of cardiac fibroblasts.
体内研究
(In Vivo)

Calhex 231 (4.07 mg/kg(10 µmol/kg);腹腔注射;每日一次;持续12周;雄性Wistar大鼠)治疗减轻了1型糖尿病模型 (T1D) 大鼠的糖尿病性心肌纤维化[2].
Calhex-231 (Cal, 0.1-1 mg/kg) 通过改善血管低反应性和减少线粒体功能障碍,对创伤性出血性休克有缓解作用[1].

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Male Wistar rats (8 weeks old) injected with Streptozotocin[2]
Dosage: 4.07 mg/kg (10 µmoL/kg).
Administration: Intraperitoneal injection; daily; for 12 weeks.
Result: Ameliorated diabetic myocardial fibrosis in T1D rats.
Animal Model: Four hundred and fifty Sprague-Dawley (SD) rats (half male and half female)[3].
Dosage: 0.1, 1, or 5 mg/kg.
Administration: A continuous infusion.
Result: In all groups, MAP, LVSP, and ±dp/dtmax decreased significantly after shock.
Administration of 5 or 1 mg/kg Cal resulted in significantly increased values at 1 and 2 hr postadministration, compared to rats in the LR only group (or 0.01).
Rats treated with 1 mg/kg Cal demonstrated the greatest recovery.
LR infusion induced short-term and slightly increase of blood pressor in normal rats.
Cal (1 mg/kg) without LR infusion did not restore the decreased MAP after shock.
分子量

406.95

Formula

C25H27ClN2O

CAS 号
运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

纯度 & 产品资料
参考文献

Calhex 231 相关分类

  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
Calhex 231
目录号:
HY-103320
需求量: